Efficacy and safety of danuglipron ( <scp>PF</scp> ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-06-20
DOI
https://doi.org/10.1111/dom.16534
Citations
9
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
11.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of danuglipron ( PF ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

Yasushi Fukushima, Sonia Cobain, Osamu Matsuoka, Donal Gorman et al.
9 citations
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
11.65
article

Efficacy and safety of danuglipron ( PF ‐06882961) in adults with obesity: A randomized, placebo‐controlled, dose‐ranging phase 2b study

Yasushi Fukushima, Sonia Cobain, Osamu Matsuoka, Donal Gorman, Patricia Halstead, Harold Edward Bays, Nikolaos Tsamandouras, Clare Buckeridge, Aditi R. Saxena, Nicole Sherry
article en
9 citations

Abstract

No abstract available for this paper.
Diabetes Obesity and MetabolismVol. 27(9)
University of Louisville (US), Pfizer (United States) (US), Pfizer (United Kingdom) (GB), Louisville Metabolic and Atherosclerosis Research Center (US)
Pfizer
Good health and well-being
Openalex Percentile: Top 1%
Diabetes Treatment and Management
11.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.